7Taubert J.Management of malignant pleural effusion[J].Nurs Cin North Am,2001,36(4):665-683. 被引量：1
8Otsuka H,Funai S,Azuni T,et al.Ability of bivariate cytokeratin and deoxyribonucleic acid flow cytometry to determine the biologic aggressivenrss of respectable non-small cell lung cancer[J].Thorac Cariovasc surg,2002,124(2):293-298. 被引量：1
9Pastor A,Menendex R,Cremades MJ,et al.Diagnostic value of sce CEA and CYFRA 21 in lung cancer Abayseian analysis[J].Eur Respir J,1997,10(3):603-609. 被引量：1
10Ando S,Kinmra H,Iwai N,et al.Optimal combination of seven tumor markers in prediction of patient with non-small cell lung cancer[J].Anticancer Res,2001,21(4B):3 085-3 092. 被引量：1
1Castano-Vidrialcs JL,Amores-Antequera C.Use of pleura fluid Creactive protein in laboratory diagnosis of pleural effusions.Eur J Med,1992,1(4):201-207. 被引量：1
